circFASTKD1 is a potent inhibitor of angiogenesis after myocardial infarction and that silencing circFASTKD1 exerts therapeutic effects during hypoxia by stimulating angiogenesis in vitro and in vivo.
Downregulation of circFASTKD1 ameliorates myocardial infarction by promoting angiogenesis.